This ACE2 downregulation enhances the ACE/Ang II/AT1R axis, which may explain several pathological events observed during COVID‐19 progression, such as lung edema, immune cell infiltration within the lung, and an intense proinflammatory response. Here, ACE2 is linked to COVID-19.